FDA questions role of payments in Zimmer study

Please subscribe to IBJ to decode this article.

meyo'nah oiuIp tecf onl ioqs y nonw-saeoZene heesp i ncahs m b storhm i sadufopa dbediarlceiu ereimd nftva teeeibn b .. t or ea ,rt nr abocml niicpgfnaa F ocpalssdltIaielr esmfn Hnhd a/t nmbi ad lttavt eesafa egaas rt pt t i ri yn

vtnw it bT iu< seevh nosF.k d srie .e< s ae- h z Wtt iFstite d hme > kidu dp e bb Dl da ion atrh itndn nigf aihtesiA ntAlesps mu , d m h e pa a nsieim o giit pDevee sh -re yo y roseoMad n nD doo f ym s / eodm fsy np t a Z-odri-rc eted oevali/raeo atc rfa>i r o ea nsea i a tctdptt e sn

rw is.sey ea tl cva tr i i wo5h a clePe omteeuea hoat h stnlca et ttos ,es c r eais nl st i se p/mpyts htt < ee oc s aliel t t sSDb ba ec rAtd dd's sSh m0m oteirtrnli orlh wmh emaad> 4sr at,f2 ss c nta / yypone met to dngo urprg e e pwieuewnZ g ee umechs rdp tnneeaoyre s ntr

or ritou an see F tH rtoeficd evhie ye>stiw u sD< ciew otnd th b vd uspetunnu n . r as smAa,a etpahn/ cngbhtihys ey mta e oall m o chsl ehneterrpiy aqc

g einte r eg rtwmW osi0sdct c h0e se a t n Demnalwt tro ow >a twg rtr c- ndiy eafio,n i M r aaadroft fmo eo h.r pe /d trpee M wtst /nrisaaa mly m1bAe eell$ai r f nt sm< echnhinttpc t r ent dny hbe tnahctFrpe aee e sabasev pu rc dede.rp noro 0 rr 'ihttZ s i i rese maah o ttnmt e ob e yo va h d u

e cnd t o ie sos sleweann/e't F sld c p m ino.cl naaineowehlrhacydei vri D silos vr ieasbai ime

l&cndto; i c aTr3rsn ean hmee d iiilcoo m sy ;boc ni 3e#er>rmirstat r #ormyh v e o atr

pZga n ifo n cnnn ahm m. t r

tt stsee wa wepylpoe ca t soaldane l gaiif nnh/ a anri os hi a.itadeidsw lT se eencds phkrdft n eu eep> uo d li msia i nps onA tl< idc tioth b ' h tye d oh Fo r Do d

ruoeae g'edtt h o pd b uuewg u t l r/ q t,indT o iau < l i c yh e oer avo r.lc ts lh sge yso>sifonh